Survival Outcomes of Local Compared With Systemic First Treatment of Non-Small Cell Lung Cancer Brain Metastases
ObjectiveThis retrospective study evaluated the survival advantage of local treatment targeted to brain metastases, relative to systemic therapy, as the first option for brain metastases of non-small cell lung cancer (NSCLC).MethodsFirst reviewed were 291 cases of NSCLC brain metastases from two cen...
Main Authors: | Hong-Mei Liu, Chun-Liu Meng, Lu-Jun Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-11-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.706409/full |
Similar Items
-
Research Progress of Targeted Therapy in Non-small Cell Lung Cancer Brain Metastases
by: Tao JIANG, et al.
Published: (2014-11-01) -
Treatment of Brain Metastases of Non-Small Cell Lung Carcinoma
by: Agnieszka Rybarczyk-Kasiuchnicz, et al.
Published: (2021-01-01) -
Editorial: Brain and leptomeningeal metastases in lung cancer
by: Tiziana Vavalà, et al.
Published: (2023-01-01) -
Intracranial Efficacy of Systemic Therapy in Patients with Asymptomatic Brain Metastases from Lung Cancer
by: Min-Gwan Sun, et al.
Published: (2023-06-01) -
Upfront Brain Treatments Followed by Lung Surgery Improves Survival for Stage IV Non-small Cell Lung Cancer Patients With Brain Metastases: A Large Cohort Analysis
by: Xiaopeng He, et al.
Published: (2021-10-01)